Skip to main content

Table 1 Composition of products accepted to each round of testing

From: A review of the WHO malaria rapid diagnostic test product testing programme (2008–2018): performance, procurement and policy

RDT type

Target antigen(s)

PDS species

Round (and year of testing)

1 (2008)

2 (2009)

3 (2010–2011)

4 (2012)

5 (2013)

6 (2014–2015)

7 (2015–2016)

8 (2016–2018)

Pf only

HRP2, Pf-LDH

Pf

16

8

15

11

9

12

19

10

Pf/pan

HRP2 or Pf,-LDH and Pan-LDH or aldolase

Pf and Pv

21

6

24

18

25

13

14

11

Pf/Pv (or Pvom)

HRP2 or Pf-LDH and Pv-LDH or Pvom-LDH

Pf and Pv

1

8

6

18

6

16

12

11

Pf, Pf and Pv

HRP2, Pf-LDH and Pv-LDH

Pf and Pv

0

0

0

0

0

0

0

1

Pf/Pv/pan

HRP2, Pv-LDH and Pan-LDH

Pf and Pv

0

2

2

0

0

0

1

0

pan only

Pan-LDH or pan-aldolase

Pf and Pv

3

4

3

1

2

0

0

2

Pv only

Pv-LDH

Pv

0

1

0

0

0

0

0

0

Total

  

41

29

50

48

42

41

46

35

  1. Pf = P. falciparum, pan = pan specific for all malaria species, Pv = P. vivax, Pvom = P. vivax, P. ovale, P. malariae. PDS species refers to the parasite species this product was tested against, for which there is a panel detection score